GAMMAGARD LIQUID for Multifocal Motor Neuropathy (MMN) Resources

Watch how GAMMAGARD LIQUID is made

See the product characteristics in this introduction to the creation process.

MMN Disease State Education Diagnosis Brochure

MMN can be challenging to diagnose.¹ This resource provides a helpful overview of the diagnostic criteria that may help you differentiate MMN from other peripheral neuropathies.

Product Characteristics Brochure

Not all IVIG formulations are interchangeable.² In this brochure, you’ll find GAMMAGARD LIQUID information related to formulation, dosage, infusion rate, and packaging along with patient risk conditions and risk factors to consider with IVIG administration.

Clinical Overview Brochure

This overview contains information on the study design, results, safety profile, and infusion experience for GAMMAGARD LIQUID’s clinical trial in MMN.

After you prescribe GAMMAGARD LIQUID to patients with MMN, they may be eligible to receive co-pay assistance through OnePath, Takeda’s patient assistance program. Let your patients know they can find program details, including how to self-enroll, at gammagard.com/mmn/resources, a resource for people with MMN and their loved ones.

There are 2 simple ways to enroll once a prescribing decision has been made. Review MMN Co-Pay Assistance Program details here.

MMN Co-Pay Assistance Enrollment Form

You or your patient’s specialty pharmacy can initiate enrollment on your patient’s behalf through OnePath using this enrollment form.

*At a minimum to be eligible, patients must have commercial insurance. Other terms and conditions apply. Contact OnePath for more information.

IMPORTANT NOTICE: The OnePath Copay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Copayment assistance under the Program is not transferable. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 1-866-888-0660. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.

MMN Electrodiagnostic Testing Overview

For your patients who need electrodiagnostic testing, this resource helps them understand what to expect during the procedure and why testing is important.

An MMN diagnosis can bring a range of emotions, from confusion to relief. Many patients and their loved ones benefit from connecting with support from patient organizations.

Neuropathy Action Foundation (NAF)

This helpful organization posts brochures, news, and quarterly newsletters and provides information on navigating insurance.

The Foundation for Peripheral Neuropathy

Along with helpful information about living with neuropathies, this organization provides opportunities for patients to connect with support groups.

The GBS/CIDP Foundation International

This organization provides support for patients with several related conditions—including MMN—and ways to connect with other patients.